Alnylam Pharmace. buy Biotechhunter
Start price
20.05.20
/
50%
€130.48
Target price
26.06.20
-
Performance (%)
6.53%
End price
26.06.20
€139.00
Summary
This prediction ended on 26.06.20 with a price of €139.00. The BUY prediction by Biotechhunter finished with a performance of 6.53%. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -0.211% | -0.211% | 35.227% | 51.013% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % | 48,88 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % | 83,74 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % | 60,39 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % | 61,27 % |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.